Skip to content

The effects of statins on exercise performance

The effects of statins on exercise performance - Statins and exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45565
Enrollment
72
Registered
2017-04-03
Start date
2017-05-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effects of statins on exericse performance the effects of statins on trainingresponse

Interventions

12-week combined endurance- and resistance training program
exercise
mitochondria
muscle function
statins and muscle complaints

Sponsors

Integrative fysiologie
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: o Age: 40-70 years old o Current statin user (group 1-2) for at least 3 months o Mentally able/ allowed to give informed consent

Exclusion criteria

Exclusion criteria: o Familial hypercholesterolemia o History of a cardiovascular event within 1 year of study participation o Known hereditary muscle defect o known mitochondrial disease o Diabetes mellitus o Contraindication for maximal incremental exercise test o Contraindication for muscle biopsy

Design outcomes

Primary

MeasureTime frame
Aim 1a. Difference in training response between the 3 groups Training response is defined as: * change in aerobic fitness ( maximal incremental cycling test) Aim 1b. * Exercise-induced change in mitochondrial mass and function * Exercise-induced change in substrate use

Secondary

MeasureTime frame
Aim 2. * Exercise-induced change in muscle strength, contractile function and fatigue, mass (voluntary force: 1 repetition maximum; contractility and fatigue assessed by electrical stimulation; mass assessed by DEXA scan) (aim 2) Aim 3. * Exercise-induced change in pain- and fatigue rating, and quality of life

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)